Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Utah
Pfizer
Abramson Cancer Center at Penn Medicine
Hackensack Meridian Health
Abramson Cancer Center at Penn Medicine
University of Nebraska
Merck Sharp & Dohme LLC
University of California, Irvine
H. Lee Moffitt Cancer Center and Research Institute
Fundación GECP
EMD Serono
Big Ten Cancer Research Consortium
University of Kansas Medical Center
Exelixis
University of Massachusetts, Worcester
Revolution Medicines, Inc.
Varian, a Siemens Healthineers Company
NantCell, Inc.
Mayo Clinic
Hackensack Meridian Health
Brigham and Women's Hospital
Swiss Cancer Institute
Amgen
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
BeiGene
Sanofi
Abramson Cancer Center at Penn Medicine
Incyte Corporation
University Health Network, Toronto
Incyte Corporation
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
National Institutes of Health Clinical Center (CC)
Takeda
Quantum Surgical
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Trishula Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Institut Bergonié
Wake Forest University Health Sciences
University of Washington
Bank of Cyprus Oncology Centre
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Hoffmann-La Roche
Pfizer
Abramson Cancer Center at Penn Medicine